Acorah Software Products - Accounts Production16.6.950falsetruefalsetrueNo description of principal activity14 March 202431 March 202531 March 202515562308Mrs Clair Clowesiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure155623082024-03-13155623082025-03-31155623082024-03-142025-03-3115562308frs-core:CurrentFinancialInstruments2025-03-3115562308frs-bus:PrivateLimitedCompanyLtd2024-03-142025-03-3115562308frs-bus:FilletedAccounts2024-03-142025-03-3115562308frs-bus:Micro-entities2024-03-142025-03-3115562308frs-bus:AuditExempt-NoAccountantsReport2024-03-142025-03-3115562308frs-bus:Director12024-03-142025-03-31
Registered number: 15562308
Clerisy Medical Writing Ltd
Unaudited Financial Statements
For the Period 14 March 2024 to 31 March 2025
Trust Accountancy Advisors Ltd
Clerisy Medical Writing Ltd
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15562308
31 March 2025
£
Fixed assets
452
Current assets
7,307
Creditors: Amounts Falling Due Within One Year
(3,394)
NET CURRENT ASSETS
3,913
TOTAL ASSETS LESS CURRENT LIABILITIES
4,365
NET ASSETS
4,365
CAPITAL AND RESERVES
4,365
Notes
1.General Information
Clerisy Medical Writing Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15562308. The registered office is 3, Dexter Way, Middlewich, CW10 9GH.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.